Your browser doesn't support javascript.
loading
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Lee, Jeong-Won; Han, Hee Dong; Shahzad, Mian M K; Kim, Seung Wook; Mangala, Lingegowda S; Nick, Alpa M; Lu, Chunhua; Langley, Robert R; Schmandt, Rosemarie; Kim, Hye-Sun; Mao, Shenlan; Gooya, John; Fazenbaker, Christine; Jackson, Dowdy; Tice, David A; Landen, Charles N; Coleman, Robert L; Sood, Anil K.
Affiliation
  • Lee JW; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
J Natl Cancer Inst ; 101(17): 1193-205, 2009 Sep 02.
Article in En | MEDLINE | ID: mdl-19641174
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Ovarian Neoplasms / Immunoconjugates / Receptor, EphA2 / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Ovarian Neoplasms / Immunoconjugates / Receptor, EphA2 / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States